Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
Panaccione R, Danese S, Sandborn WJ, O'Brien CD, Zhou Y, Zhang H, Adedokun OJ, Tikhonov I, Targan S, Abreu MT, Hisamatsu T, Scherl EJ, Leong RW, Rowbotham DS, Arasaradnam RP, Sands BE, Marano C.
Panaccione R, et al. Among authors: scherl ej.
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1658-1675. doi: 10.1111/apt.16119. Epub 2020 Oct 21.
Aliment Pharmacol Ther. 2020.
PMID: 33086438
Free PMC article.
Clinical Trial.